{"id":"https://openalex.org/W2802449910","doi":null,"title":"Atezolizumab for treating locally advanced or metastatic urothelial carcinoma","display_name":"Atezolizumab for treating locally advanced or metastatic urothelial carcinoma","publication_year":2017,"publication_date":"2017-09-15","ids":{"openalex":"https://openalex.org/W2802449910","mag":"2802449910"},"language":"en","primary_location":{"id":"pmh:oai:eprints.soton.ac.uk:416506","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/id/eprint/416506/1/Atezolizumab_for_treating_locally_advanced_or_metastatic_urothelial_carcinoma.pdf","pdf_url":"https://eprints.soton.ac.uk/id/eprint/416506/1/Atezolizumab_for_treating_locally_advanced_or_metastatic_urothelial_carcinoma.pdf","source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Monograph"},"volume":null,"type":"book","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076758337","display_name":"Keith Cooper","orcid":"https://orcid.org/0000-0002-0318-7670","observed_orcids":["https://orcid.org/0000-0002-0318-7670"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cooper, Keith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015678366","display_name":"Neelam Kalita","orcid":"https://orcid.org/0000-0002-0973-0160","observed_orcids":["https://orcid.org/0000-0002-0973-0160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kalita, Neelam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054066646","display_name":"Olu Onyimadu","orcid":"https://orcid.org/0000-0002-1724-3485","observed_orcids":["https://orcid.org/0000-0002-1724-3485"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Onyimadu, Oluchukwu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080479674","display_name":"Jillian L Colquitt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colquitt, Jillian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075935196","display_name":"Emma Loveman","orcid":"https://orcid.org/0000-0001-8226-2634","observed_orcids":["https://orcid.org/0000-0001-8226-2634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Loveman, Emma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5017626288","display_name":"Geoff K Frampton","orcid":"https://orcid.org/0000-0003-2005-0497","observed_orcids":["https://orcid.org/0000-0003-2005-0497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frampton, Geoffrey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":1.0},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/locally-advanced-urothelial-carcinoma","display_name":"locally advanced urothelial carcinoma","score":0.8560000061988831},{"id":"https://openalex.org/keywords/metastatic-urothelial-carcinoma","display_name":"metastatic urothelial carcinoma","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8230000138282776},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8981589078903198},{"id":"https://openalex.org/C2911057145","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Metastatic Urothelial Carcinoma","level":5,"score":0.788546085357666},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6159844994544983},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.4834459722042084},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4820486009120941},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3131105899810791},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.274120956659317},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.23901110887527466},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.23207435011863708},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.13102778792381287}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:eprints.soton.ac.uk:416506","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/id/eprint/416506/1/Atezolizumab_for_treating_locally_advanced_or_metastatic_urothelial_carcinoma.pdf","pdf_url":"https://eprints.soton.ac.uk/id/eprint/416506/1/Atezolizumab_for_treating_locally_advanced_or_metastatic_urothelial_carcinoma.pdf","source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Monograph"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2539352419","https://openalex.org/W4388157987","https://openalex.org/W6980091278","https://openalex.org/W4249543285","https://openalex.org/W6941046002","https://openalex.org/W2743468821","https://openalex.org/W4388160530","https://openalex.org/W3103428497","https://openalex.org/W4388161006","https://openalex.org/W2796506173"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}